The radiation-induced fibroatrophic process (RIF) constitutes a late, local and unavoidable
sequela to high-dose radiotherapy, traditionally considered irreversible. Today, this process …

Purpose The aim of this study was to review the available literature and define clinical
practice guidelines for the use of agents for the prevention and treatment of gastrointestinal …

BACKGROUND Oral and gastrointestinal (GI) mucositis can affect up to 100% of patients
undergoing high‐dose chemotherapy and hematopoietic stem cell transplantation, 80% of …

Radiation-induced fibrosis (RIF) and radionecrosis (RN) are late complications that are
usually considered irreversible. Usual management strategy includes eliminating local and …

PURPOSE: Cancer patients who undergo radiotherapy remain at life-long risk of radiation-
induced injury to normal tissues. We conducted a randomized, controlled, double-blind …

Acute radiation cystitis occurs during or soon after radiation treatment. It is usually self-
limiting, and is generally managed conservatively. Late radiation cystitis, on the other hand …

Approximately 1.2 million new cases of invasive cancer will be diagnosed this year in the
United States and approximately one half of these patients will receive radiation therapy as …

Radiation-induced fibrosis (RIF) represents one of the most common long-term adverse
effects of curative radiotherapy. Current cancer treatment approaches, involving more …

Late complications are one of the major factors limiting radiotherapy treatment, and their
treatment is not codified. Hyperbaric oxygen (HBO) has been used in combination with …

PURPOSE: Hemorrhagic cystitis can occur 6 months to 10 years after pelvic radiation
therapy with moderate to severe persistent rates of hematuria as 3% to 5% after …